Discontinuation report APO-BRIMONIDINE
| Report ID | 60294 |
| Drug Identification Number | 02260077 |
| Brand name | APO-BRIMONIDINE |
| Common or Proper name | BRIMONIDINE |
| Company Name | APOTEX INC |
| Market Status | DORMANT |
| Active Ingredient(s) | BRIMONIDINE TARTRATE |
| Strength(s) | 0.2% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 10 ml |
| ATC code | S01EA |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-06-02 |
| Actual discontinuation date | |
| Remaining supply date | 2019-06-02 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-09-07 | English | Compare |
| v2 | 2018-09-07 | French | Compare |
Showing 1 to 2 of 2